Dr. Erika Resetkova, MD, PhD

Dr. Resetkova practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Resetkova's NPI, 1063505659, was assigned on October 2, 2006. Dr. Resetkova graduated from Comenius University in 1984. Dr. Resetkova holds Texas license L9868.

Dr. Resetkova's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Resetkova's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Resetkova practices. Vendor and product names are available with a free account.

Cytopathology is Dr. Resetkova's primary specialty in the NPI Registry, under taxonomy code 207ZC0500X. Dr. Resetkova is board certified in anatomic pathology & clinical pathology by the American Board of Pathology. Dmand AI has Dr. Resetkova's licenses on file in 2 states: Texas and California.

CMS data shows 903 Medicare services from Dr. Resetkova across 9 procedure codes in 2024, for 279 Medicare patients. Medicare paid $33,414 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 279 Medicare patients who saw Dr. Resetkova in 2024. The largest group is 65 to 74, with 190 patients. 75% of them have cancer, and 72% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Resetkova's median patient age at 58, with 99% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Resetkova for performance year 2024, reported as part of a group. Dr. Resetkova accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 68 papers to Dr. Resetkova, published from 2007 to 2025. 2019 was the busiest year, with 3. The most frequent topics are Breast Neoplasms, Graves Disease and Thyroid Gland. Dr. Resetkova has published most often in Arch Pathol Lab Med. Dr. Resetkova's most frequent co-authors are Constance T. Albarracin, MD, PhD, Aysegul A. Sahin, MD and Lei Huo, MD.

CMS Open Payments shows 1 general payment to Dr. Resetkova from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Pacira Pharmaceuticals Incorporated paid the most, $125.

Dr. Resetkova graduated from Comenius University in 1984.

Dr. Resetkova is in network with 3 carriers, including Aetna, Blue Cross Blue Shield of Michigan and CMS Medicare. HMO plans come from the most carriers, 2. Check the plan with the practice before a visit.